Home
Resources
Publications
Current State of the Nanoscale Delivery Systems for Temoporfin-Based Photodynamic Therapy: Advanced Delivery Strategies

Current State of the Nanoscale Delivery Systems for Temoporfin-Based Photodynamic Therapy: Advanced Delivery Strategies

Ilya Yakavets, Marie Millard, Vladimir Zorin, Henri-Pierre Lassalle, Lina Bezdetnaya

J Control Release. 2019 Jun 28;304:268-287.

PMID: 31136810

Abstract:

Enthusiasm for photodynamic therapy (PDT) as a promising technique to eradicate various cancers has increased exponentially in recent decades. The majority of clinically approved photosensitizers are hydrophobic in nature, thus, the effective delivery of photosensitizers at the targeted site is the main hurdle associated with PDT. Temoporfin (mTHPC, medicinal product name: Foscan®), is one of the most potent clinically approved photosensitizers, is not an exception. Successful temoporfin-PDT requires nanoscale delivery systems for selective delivery of photosensitizer. Over the last 25 years, the number of papers on nanoplatforms developed for mTHPC delivery such as conjugates, host-guest inclusion complexes, lipid-and polymer-based nanoparticles and carbon nanotubes is burgeoning. However, none of them appeared to be "ultimate". The present review offers the description of different challenges and achievements in nanoparticle-based mTHPC delivery focusing on the synergetic combination of various nano-platforms to improve temoporfin delivery at all stages of biodistribution. Furthermore, the association of different nanoparticles in one nanoplatform might be considered as an advanced strategy allowing the combination of several treatment modalities.

Chemicals Related in the Paper:

Catalog Number	Product Name	Structure	CAS Number	Price
AP122341382	Temoporfin		122341-38-2	Price

As a specialist in analytical chemical Products, Alfa Chemistry offers consumers a wealth of raw materials and a full range of technologies and services.

QUICK LINKS

HEADQUARTERS

Tel:

Fax:

Email: